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Background. The SpyGlass Direct Visualization System (Boston Scientific, Natick, MA) is routinely used during single operator
choledochoscopy (SOC) to identify biliary lesions or strictures with a diagnostic accuracy up to 88%. The objective of this study
was to determine the interobserver agreement (IOA) of modified scoring criteria for diagnosing biliary lesions/strictures. Methods.
27 SPY SOC video clips were reviewed and scored by 9 interventional endoscopists based on published criteria that included the
presence and severity of surface structure, vasculature visualization, lesions, and findings. Results. Overall IOA was “slight” for all
variables. The K statistics are as follows: surface (𝐾 = 0.12, SE = 0.02); vessels (𝐾 = 0.14, SE = 0.02); lesions (𝐾 = 0.11, SE = 0.02);
findings (𝐾 = 0.08, SE = 0.03); and final diagnosis (𝐾 = 0.08, SE = 0.02). The IOA for “findings” and “final diagnosis” was also only
“slight.” The final diagnosis was malignant (11), benign (11), and indeterminate (5). Conclusion. IOA using the modified criteria of
SOC images was slight to almost poor. The average accuracy was less than 50%. These findings reaffirm that imaging criteria for
benign and malignant biliary pathology need to be formally established and validated.

1. Introduction
The role of cholangioscopy in the diagnosis of biliary strictures is being more widely advocated with increased availability of cholangioscopy systems. The earlier “mother-daughter”
systems introduced in the 1970s are being replaced in
many practices by the single operator cholangioscopy system
(SOCS), which overcomes many of the limitations of these
older instruments. The SpyGlass Direct Visualization System
(Boston Scientific, Natick, MA) is currently the only SOCS

commercially available in the United States. Advantages
that this device offers over the older systems include fourway steerability, dedicated irrigation channels, and a 1.2 mm
working channel through which diagnostic and therapeutic
devices can be used [1, 2]. Peroral video cholangioscopy
systems (PVCS) are also available in select Asian countries
and on trial basis in the United States and provide superior
imaging quality. Common indications for cholangioscopy
are stone therapy and evaluation of indeterminate biliary
strictures [1–6].
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Studies using the SOCS report diagnostic sensitivities for
malignancy of 66–78% and specificities of 82–98% [7, 8].
Reports using the PVCS report sensitivity of 100% and specificity of >90% [9]. While the largest multicenter study using
SOCS demonstrated high diagnostic accuracy with visualization alone, there was no indication of criteria that were
used by the individual investigators in making diagnosis of
malignancy [8]. A previous study attempted to establish criteria for the cholangioscopic diagnosis of intraductal pathology by using criteria devised by a single investigator that
had allowed for self-assessed accuracy of 90%. When
reviewed by multiple observers, however, the interobserver
agreement (IOA) of these criteria when viewing video clips
was poor [10]. Subsequently, imaging features obtained by
PVCS that were felt to be diagnostic of malignancy were
published [11]. The objective of this study was to determine
the IOA using modified scoring criteria, based on these newly
suggested cholangioscopic images, for diagnosing biliary
lesions/strictures.

2. Methods
Twenty-seven deidentified SPY single operator choledochoscopy video clips and scoresheets were sent out to 9 interventional endoscopists. Each of these endoscopists routinely
performs SOC, having performed more than 50 individually.
The reviewers were blinded to clinical information related
to the indication of the choledochoscopy and the final
diagnosis and were not provided correlating fluoroscopic
images. The video clips’ duration ranged from 1 to 2 minutes.
All of the procedures were performed by one expert in
choledochoscopy (Michel Kahaleh) over a two-year time
period using the same SPY unit. The videos were composed
of extracted segments from the procedures and contained
images of intraductal strictures and lesions. No video clips
were excluded due to poor quality and no annotations or
labeling was included in the video clips.
The endoscopists were asked to score the videos using a
scoring system based on the criteria published by Itoi et al.
in 2009. The clips were scored based on presence and severity
of four features: surface structure (flat surface, bumpy surface,
and convergence of folds), vasculature visualization (fine network of normal vessels, increased vasculature without bleeding, and increased vasculature with bleeding), lesions (regular
granular lesions/hyperplasia, irregularly papillary or granular
lesions, and nodular elevated lesions), and findings (normal,
inflammation, scar, and cancer). The observers were also
asked to choose one of the following final diagnoses: benign,
malignant, or indeterminate.
2.1. Statistical Analysis. The interobserver agreements for 4
variables and final diagnosis variable were measured using
the Fleiss’ kappa statistic along with 95% CI. All calculations
were performed using SAS version 9.2. 𝐾 statistics were
interpreted based on the convention by Landis and Koch:
poor agreement, ≤0; slight agreement, 0.01 to 0.20; fair agreement, 0.21–0.40; moderate agreement, 0.41–0.60; substantial
agreement, 0.61–0.80; and almost perfect agreement: 0.81–
1.00.
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3. Results
Twenty-seven videos were sent to 9 observers. Forty-one percent (11/27) of the videos featured malignant lesions. Overall
interobserver agreement was “slight” for scoring of surface
structures (𝐾 = 0.12, 𝑃 value < 0.0001, and SE = 0.02) and
for characterization of vessels (𝐾 = 0.14, 𝑃 value < 0.0001,
and SE = 0.02) and lesions (𝐾 = 0.11, 𝑃 value < 0.0001, and
SE = 0.02). The IOA was also only “slight” for describing findings (𝐾 = 0.08, 𝑃 value < 0.0001, and SE = 0.03) and for providing a final diagnosis (𝐾 = 0.08, 𝑃 value = 0.0004, and SE =
0.02).
There was slight to poor agreement on video quality as
well. It was felt that there were too few clips to statistically
measure accuracy.

4. Discussion
It has been shown that direct visualization with the cholangioscopy system improves the accuracy of cholangiographic
findings in evaluating patients with biliary obstructive symptoms of indeterminate origin [3, 4, 12–15]. Cholangioscopy
also allows for obtaining biopsies under direct visualization.
This sampling method has been shown to have sensitivities
of 48.9%–76.5%; however, when compared to the sensitivity
of a visually based diagnosis, the sensitivity was lower
(77.8% versus 48.9%) [8, 13]. The values of a visually based
impression may then be to provide accurate diagnosis or
to help guide management even in the absence of tissue
confirmation of malignancy. Nishikawa et al. reported a 97%
accuracy of PVCS imaging of biliary lesions [9]. Recently,
Woo et al.’s study showed that the sensitivity, specificity, and
overall accuracy of SpyGlass visual assessment and SpyBite
biopsy for the diagnosis of malignancy were 100% (21/21)
and 64.2% (9/14), 90% (9/10) and 100% (5/5), and 96.7%
(30/31) and 73.6% (14/19), respectively [16]. However, both
of these studies were performed by single centers. Characteristics of a valid imaging-based diagnostic system are
considered to be reproducible and high interobserver agreements when viewed objectively. While diagnostic criteria
have been proposed using a video cholangioscopy system, our
study demonstrates that the interobserver agreement using
the modified criteria for interpretation of cholangioscopic
images obtained by a SOC is only slight to almost poor.
These findings would suggest that the features of malignant
lesions as seen by video cholangioscopy cannot be directly
applied to the use of SOCS with satisfactory reproducibility or
interobserver agreement. Furthermore, the fair to poor agreement in using these criteria with this cholangioscopy system
would suggest that little value should be placed in visual
impressions alone and that the diagnostic accuracies reported
for choledochoscopy are highly dependent on additional
factors such as clinical history and prior ERCP impression
and thus may result in the reporting of inflated accuracy
levels. Fukuda and others showed that the sensitivity of
combined ERCP with cholangioscopy in diagnosing biliary
lesions was 93% compared with only 58% for ERCP alone
[17]. There was also a superiority of cholangioscopy with
biopsy in differentiating benign from malignant lesions with
an accuracy of 100% [17].
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There are a number of limitations to this study. The most
apparent one is that the criteria or features chosen for scoring
were not guided by standardized definitions; rather, a scoring
system based on the criteria published by Itoi et al. in 2009
was used [11]. Even these criteria had not been validated
at the time this study was performed. Another understood
limitation is that this is a small retrospective study. The retrospective nature of the study further limits this study in that
qualities of the individual optical probes used for the clips
cannot be provided nor can standardized length or quality
of representative footage be provided. It is interesting to note
that when asked to rate the quality of the video, there was
only slight to poor agreement. This raises the question of
whether measures of quality assurance should be developed
and standardized in the future as well.
The results of this study show that interobserver agreements of choledochoscopy images range from slight to almost
poor. While there is no doubt that PVCS provide superior
imaging to the current fiber optic system used in SOC and
provide valuable tools in diagnosing biliary neoplasms, their
widespread applicability is limited. In an environment where
the current fiber optic system is the dominant system being
used worldwide, efforts should be made to establish criteria
or revise currently published criteria that are specific to this
mode of imaging or that can be consistently accurate across
all systems. As with any criteria-based system, these should
be validated in further studies. Once established, proficiency
in identifying these criteria should be achieved when training
to use cholangioscopy for diagnostic purposes.
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